Charles River Clinical Services
Tacoma, Washington, 98418, United States
NCT Number: NCT00841594
The purpose of this clinical study is to compare the pharmacokinetic profiles of a topical cream formulation of 0.9% nitroglycerin, MQX 503, and Nitroglycerin Ointment 2%, USP.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Phase 1
Tacoma, Washington, 98418, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MQX-503, topical cream for nitroglycerin 0.9% vs Nitroglycerin ointment 2%, USP.
MQX-503, topical cream for nitroglycerin 0.9% vs Nitroglycerin ointment 2%, USP.
Time frame: 12 hours
Time frame: 3 weeks
MediQuest Therapeutics
Industry
MXQ-503 Applied To The Hand Vs. Nitroglycerin Ointment 2%, USP, Applied To The Chest: A Pharmacokinetic Comparison In Normal Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02583789
Cardiovascular Diseases, Embolism and Thrombosis
Boston, Massachusetts, United States
View Trial DetailsNCT03058887
Behavior, Cardiovascular Diseases
Sheffield, United Kingdom
View Trial DetailsNCT02506062
Cardiovascular Diseases, Embolism and Thrombosis
London, Ontario, Canada
View Trial DetailsNCT02050360
Cardiovascular Diseases, Connective Tissue Diseases
Grenoble, France
View Trial Details